Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Gross Margin 2021–2025
Current and historical gross margin for Kiniksa Pharmaceuticals International, plc (KNSA) over the last 10 years. The current gross profit margin for Kiniksa Pharmaceuticals International, plc as of December 31, 2025 is 88.54%.
From: 12/31/2021To: 12/31/2025
Revenue
Gross Profit
Gross Margin
Kiniksa Pharmaceuticals International, plc Gross Margin — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) gross margin over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Kiniksa Pharmaceuticals International, plc's gross margin?
Kiniksa Pharmaceuticals International, plc (KNSA) reported gross margin of 88.5% for fiscal 2025.
Where can I see KNSA's gross margin history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's gross margin by year and by quarter, including the growth rate.